Assignee
MERUS NV
NL·43 granted patents·54 pending applications·170 citations·filing 2013–2025
Top patents by PatentIndex Score
97 records- 0197US11926859B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2023·Granted Mar 12, 2024·2 cites·7 claims
- 0297US9758805B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2015·Granted Sep 12, 2017·23 cites·43 claims
- 0396US12139548B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2022·Granted Nov 12, 2024·4 cites·20 claims
- 0495US12247078B2ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2024·Granted Mar 11, 2025·3 cites·20 claims
- 0595US10605808B2Antibody producing non-human animalsMERUS NV·Filed 2016·Granted Mar 31, 2020·19 cites·9 claims
- 0694US11237165B2Antibody producing non-human animalsMERUS NV·Filed 2017·Granted Feb 1, 2022·5 cites·14 claims
- 0794US10752929B2Methods and means for the production of ig-like moleculesMERUS NV·Filed 2019·Granted Aug 25, 2020·5 cites·15 claims
- 0894US10670599B2Method for selecting a single cell expressing a heterogeneous combination of antibodiesMERUS NV·Filed 2017·Granted Jun 2, 2020·6 cites·13 claims
- 0993US10934571B2Recombinant production of mixtures of antibodiesMERUS NV·Filed 2016·Granted Mar 2, 2021·4 cites·20 claims
- 1093US9951124B2Antibody producing non-human mammalsMERUS NV·Filed 2013·Granted Apr 24, 2018·10 cites·4 claims
- 1192US10844127B2Antibodies that bind EGFR and ErbB3MERUS NV·Filed 2015·Granted Nov 24, 2020·8 cites·18 claims
- 1292US10647781B2Generation of binding moleculesMERUS NV·Filed 2017·Granted May 12, 2020·6 cites·7 claims
- 1392US9914777B2Human CD3 binding antibodyMERUS NV·Filed 2016·Granted Mar 13, 2018·11 cites·18 claims
- 1491US11820825B2Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumorMERUS NV·Filed 2020·Granted Nov 21, 2023·2 cites·12 claims
- 1591US11408095B2Generation of binding moleculesMERUS NV·Filed 2020·Granted Aug 9, 2022·2 cites·7 claims
- 1690US11279770B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2015·Granted Mar 22, 2022·7 cites·17 claims
- 1790US2024344102A1Methods and means for the production of ig-like moleculesMERUS NV·Filed 2024·Application pending·0 cites
- 1889US11559049B2Antibody producing non-human animalsMERUS NV·Filed 2018·Granted Jan 24, 2023·2 cites·7 claims
- 1989US10358492B2Bispecific IgG antibodies as T cell engagersMERUS NV·Filed 2013·Granted Jul 23, 2019·11 cites·30 claims
- 2088US12123043B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2020·Granted Oct 22, 2024·1 cites·26 claims
- 2188US10329596B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2016·Granted Jun 25, 2019·4 cites·34 claims
- 2288US10266593B2Human CD3 binding antibodyMERUS NV·Filed 2018·Granted Apr 23, 2019·6 cites·19 claims
- 2387US11993654B2PD-1 binding domainsMERUS NV·Filed 2022·Granted May 28, 2024·1 cites·20 claims
- 2487US11732043B2Antibodies that modulate a biological activity expressed by a cellMERUS NV·Filed 2018·Granted Aug 22, 2023·3 cites·22 claims
- 2587US10337045B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2017·Granted Jul 2, 2019·3 cites·56 claims
- 2687US2024023527A1Antibody producing non-human animalsMERUS NV·Filed 2023·Application pending·0 cites
- 2787US2024156072A1Antibody producing non-human animalsMERUS NV·Filed 2023·Application pending·0 cites
- 2886US11780925B2ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 2985US12195551B2Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancerMERUS NV·Filed 2018·Granted Jan 14, 2025·3 cites·9 claims
- 3085US11667714B2Binding molecules that modulate a biological activity expressed by a cellMERUS NV·Filed 2018·Granted Jun 6, 2023·3 cites·48 claims
- 3183US2024158532A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2024·Application pending·0 cites
- 3282US11753470B2Bispecific anti PD1-anti TIM3 antibodiesMERUS NV·Filed 2018·Granted Sep 12, 2023·2 cites·14 claims
- 3381US12291798B2Generation of binding moleculesMERUS NV·Filed 2022·Granted May 6, 2025·0 cites·12 claims
- 3481US11952424B2Multivalent antibodyMERUS NV·Filed 2019·Granted Apr 9, 2024·1 cites·47 claims
- 3581US2024158531A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2024·Application pending·0 cites
- 3681US2024109966A1Human cd3 binding antibodyMERUS NV·Filed 2023·Application pending·0 cites
- 3781US2025026823A1Bispecific igg antibodies as t cell engagersMERUS NV·Filed 2024·Application pending·0 cites
- 3881US2025230579A1Generation of binding moleculesMERUS NV·Filed 2025·Application pending·0 cites
- 3980US11939394B2Binding molecules that inhibit cancer growthMERUS NV·Filed 2016·Granted Mar 26, 2024·4 cites·30 claims
- 4080US2024352127A1Multivalent antibodyMERUS NV·Filed 2024·Application pending·0 cites
- 4180US2024360217A1Multivalent antibodyMERUS NV·Filed 2024·Application pending·0 cites
- 4278US11873338B2CLEC12AxCD3 bispecific antibodies and methods for the treatment of diseaseMERUS NV·Filed 2019·Granted Jan 16, 2024·2 cites·13 claims
- 4378US2022348683A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2022·Application pending·0 cites
- 4478US2024052043A1Antibodies that bind egfr and erbb3MERUS NV·Filed 2023·Application pending·0 cites
- 4578US2024199747A1Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment of cells that have an nrg1 fusion geneMERUS NV·Filed 2023·Application pending·0 cites
- 4676US11685786B2Binding molecules that bind CD137 and PD-L1MERUS NV·Filed 2017·Granted Jun 27, 2023·1 cites·10 claims
- 4776US2024425594A1Novel pd-1 binding domainsMERUS NV·Filed 2024·Application pending·0 cites
- 4876US2024425595A1Novel pd-1 binding domainsMERUS NV·Filed 2024·Application pending·0 cites
- 4973US12577306B2Bispecific anti PD1-anti TIM3 antibodiesMERUS NV·Filed 2023·Granted Mar 17, 2026·0 cites·28 claims
- 5073USRE47770ERecombinant production of mixtures of antibodiesMERUS NV·Filed 2016·Granted Dec 17, 2019·1 cites·26 claims
Showing the top 50 of 97 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →